Period of time： 2013年3期
Publisher： Springer Publishing Company
Founded in： 2006
Total resources： 10
ISSN： 1776-2596
Subject： R73 Oncology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Targeted Oncology,volume 2,issue 3
Menu
Normalization, inhibition, rarefaction?
By Morère Jean-François in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.
Access to resources
Recommend
By Behrens Diana,Lykkesfeldt Anne,Fichtner Iduna in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.By Akagi Kiwamu,Sakai Hiroshi,Sudo Junko,Hommura Yasuo,Kurimoto Futoshi,Komagata Hiroshi,Akiyama Hirohiko,Yoneda Shuichi in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.Targeted therapy in advanced colorectal cancer, an update
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.Radioimmunotherapy (RIT) in non-Hodgkin lymphoma
By Kyle Fiona,Pettengell Ruth in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis
By Ghoul Aïda,Serova Maria,Tourneau Christophe,Aïssat Nasredine,Hammel Pascal,Raymond Eric,Faivre Sandrine in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.By Medioni Jacques,Cojocarasu Oana,Banu Eugeniu,Cassar-Queudeville Alexia,Halimi Philippe,Oudard Stéphane in (2007)
Targeted Oncology,volume 2,issue 3 , Vol. 2, Iss. 3, 2007-07 , pp.